Chemists and chemical biologists just keep dreaming up new ways to interfere with biomolecules. That research frequently leads to promising potential medicines, and there are more and more flavors of ...
TherML™ integrates CombinAbleAI’s advanced, next generation biologics expertise with insitro’s existing small molecule and oligonucleotide capabilities, unifying therapeutic design across all major ...
The analysis examined overall program counts as well as distribution by development stage, drug modality, and therapeutic area. Growth in early-stage development was observed across multiple countries ...
Organoid screening platforms are transforming drug discovery by providing physiologically relevant 3D models that improve ...
WASHINGTON — Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to ...